Study population | Study population Le Mans | Study population Cagliari | P Le Mans vs Cagliari | |
---|---|---|---|---|
N | 180 | 97 | 83 | – |
Males/Females | 59.4% 40.6% | 55.7% 44.3% | 63.9% 36.1% | 0.336 |
Age median (yrs) (min-max) | 69 (18–90) | 71 (18–90) | 67 (26–89) | 0.020 |
RRT vintage (yrs) (min-max) | 6.7 (0.07–43.5) | 4.3 (0.07–43.5) | 10.3 (0.5–36.9) | < 0.001 |
Charlson median (min-max) | 8 (2–16) | 9 (2–16) | 6 (2–12) | < 0.001 |
MIS median (min-max) | 7 (1–27) | 7 (1–23) | 6 (2–27) | 0.020 |
SGA: A | 61.1% | 49.5% | 74.7% | 0.002 |
SGA: B | 33.9% | 45.4% | 20.5% | |
SGA: C | 5.0% | 5.2% | 4.8% | |
HD-HDF (%) | HD: 40.0% HDF: 60.0% | HD: 23.7% HDF: 76.3% | HD: 59.0% HDF: 41.0% | < 0.001 |
BMI Kg/m2 median (min-max) | 24.3 (14.6–47.1) | 26.2 (16.4–47.1) | 22.6 (14.6–31.8) | < 0.001 |
BMI < 20 | 32 (18.0%) | 11 (11.6%) | 21 (25.3%) | < 0.001 |
BMI 20–25 | 66 (37.1%) | 26 (27.4%) | 40 (48.2%) | |
BMI 25–30 | 56 (31.5%) | 38 (40.0%) | 18 (21.7%) | |
BMI > = 30 | 24 (13.5%) | 20 (21.1%) | 4 (4.8%) | |
Albumin (g/dl) median (min-max) | 3.4 (2.0–4.5) | 3.2 (2.6–3.8) | 3.7 (2.0–4.5) | < 0.001 |
Albumin < 3 | 23 (12.8%) | 22 (22.7%) | 1 (1.2%) | < 0.001 |
Albumin < 3.5 | 99 (55.0%) | 78 (80.4%) | 21 (25.3%) | < 0.001 |
BUN (mg/dl) median (min-max) | 60.0 (24.4–105) | 56.7 (24.4–100) | 63.0 (32.0–105) | 0.015 |
Creatinine (mg/dl) median (min-max) | 9.1 (2.7–15.0) | 8.8 (2.7–15.0) | 10.2 (3.6–14.8) | 0.003 |
Cholesterol (mg/dl) median (min-max) | 158 (49–263) | 162.8 (49–249) | 157 (67–263) | 0.978 |
Kt/V median (min-max) | 1.6 (0.7–2.3) | 1.5 (0.7–2.2) | 1.6 (0.8–2.3) | 0.005 |
nPCR (g/Kg/day) median (min-max) | 1.04 (0.5–1.8) | 0.9 (0.5–1.7) | 1.1 (0.6–1.8) | 0.002 |